May 13 (Reuters) - Mylan Inc:
* Launches first generic version of Amrix capsules
* Says company will have 180 days of marketing exclusivity
* Says Cyclobenzaprine HCL ER capsules are the generic version of Cephalon's
Amrix capsules
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Launches first generic version of Amrix capsules
* Says company will have 180 days of marketing exclusivity
* Says Cyclobenzaprine HCL ER capsules are the generic version of Cephalon's
Amrix capsules
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.